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Received March 7, 2011; accepted December 29, 2011AbstractBackground: Endovascular detachable coil embolization has become an important method in the management of intracranial aneurysms.
However, coil embolization alone may fail to treat some wide-neck aneurysms. Herein, we report our experience with and outcome of stent-
assisted coil embolization (SACE) of intracranial aneurysms.
Methods: Over a 5-year period, a total of 59 patients diagnosed with 63 intracranial aneurysms underwent SACE. Of the total 63 aneurysms, 6
aneurysms were treated by SACE as a salvageable procedure because of coil instability after detachment. There were 17 men and 42 women
enrolled in the study, with ages ranging from 24 to 86 years (mean: 60 years). We retrospectively assessed the clinical data, aneurysm char-
acteristics, and angiographic and clinical outcomes of all patient cases.
Results: The mean aneurysm size was 9.4 mm, and the mean neck size was 5.5 mm. Clinical and angiographic follow-up exceeding 6 months
were available in 51 and 40 patients, respectively. The mean clinical follow-up time was 28 months (range: 6e49 months). Successful stent
deployment was found in 60 aneurysms (95%). Midterm total or subtotal angiographic aneurismal occlusion was obtained in 56 aneurysms
(89%), with further thrombosis of the aneurismal sac occurring in 4 (10%). Stable coiling aneurysm was found in 24 (78%), aneurysm recurrence
was observed in 5 (13%), and permanent procedural morbidity was observed in two patients (3.4%). During the follow-up period, there were no
hemorrhagic events and no stent displacement.
Conclusion: Despite a modest procedural complication rate, and some evidence of aneurismal recurrence, SACE was proved to be both effective
and safe in managing wide-neck intracranial aneurysms. Our results also demonstrated the midterm durability and stability of aneurysm treated
by SACE. Furthermore, SACE can be a salvageable procedure in cases with coil instability after detachment.
Copyright  2012 Elsevier Taiwan LLC and the Chinese Medical Association. All rights reserved.
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As shown in an earlier clinical trial, endovascular detach-
able coil embolization of intracranial aneurysms has become
a more widely recognized alternative treatment modality to* Corresponding author. Dr. Chao-Bao Luo, Department of Radiology,
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doi:10.1016/j.jcma.2012.05.003neurosurgical aneurysm clipping.1 Despite the increase in
clinical experience and improvements in technology, endo-
vascular treatment still has inherent limitations in the
management of geographically-difficult intracranial aneu-
rysms such as wide-neck aneurysms. The most common
complication of endovascular embolization of wide-neck
aneurysm is coil herniation into the parent artery, leading to
a thromboembolic event, insufficient aneurysm sac coiling, or
to coil compacting with a recurrent aneurysm.2 Although use
of the balloon remodeling technique3 and use of two- or three-hinese Medical Association. All rights reserved.
Table 1
Demography of 59 patients with 63 aneurysms treated by SACE.
Characteristics Number (percentage)
Sex (n ¼ 59)
Female 42 (71)
Male 17 (29)
Age (y, mean age: 60) (n ¼ 59)
<40 2 (3)
40-49 10 (17)
50-59 22 (37)
60-69 11 (19)
70-79 8 (14)
>80 6 (10)
Clinical presentation in 63 aneurysms (n ¼ 63)
SAH 25 (40)
Previous SAH from another aneurysm 4 (6)
Aneurysm recurrence after embolization 1 (2)
Cranial nerve impairment 7 (11)
Transient ischemic attack 5 (8)
Incident finding 21 (33)
SAH ¼ subarachnoid hemorrhage; SACE ¼ stent-assisted coil embolization.
Table 2
Characteristics of 63 aneurysms treated by SACE (n ¼ 63).
Characteristics Number (percentage)
Size (mm)
<7 33 (52)
7e12 16 (25)
13e24 13 (21)
>24 1 (2)
Site of aneurysm
Internal carotid artery 50 (79)
Supraclinoid ICA 34 (54)
Paraclinoid ICA 10 (16)
Cavernous ICA 6 (10)
Middle cerebral artery 1 (2)
Basilar artery 4 (6)
Vertebral artery 7 (11)
Posterior cerebral artery 1 (2)
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technique5 may help to obtain better morphologic results in
the treatment of wide-neck aneurysms, insufficient coil
packing and/or recurrence is still a major problem.3e5 Since
the advent of the intracranial stent, stent-assisted coil embo-
lization (SACE) of an aneurysm has the capability to facilitate
the management of intracranial wide-neck aneurysms to
prevent coil protrusion into the parent vessel, which may allow
for the safer and denser packing of the aneurysm sac.6e8
However, the mid- or long-term effects of SACE of wide-
neck aneurysms have not been well-evaluated.
The purpose of our study was to report our experience
using SACE to manage intracranial aneurysms and to report
the midterm outcome of this technique.
2. Methods
From January 2005 to December 2010, a series of 216
consecutive patients harboring 238 intracranial aneurysms
underwent endovascular coil embolization procedure in our
institute. Of these, 59 patients with 63 aneurysms underwent
SACE because of wide-neck aneurysms (n ¼ 57), with necks
larger than 4 mm and/or dome-to-neck ratio greater than 1.5,
or SACE as a salvageable procedure (n ¼ 6). There were 17
men and 42 women between the ages of 24e86 years (mean:
60 years). This study was approved by the Institutional Review
Board of the Taipei Veterans General Hospital (VGHIRB No:
2010110011A). Information including sex, age distribution,
clinical manifestations and characteristics of aneurysms
treated by SACE are summarized in Tables 1 and 2. Of these
aneurysms, 25 cases presented with acute subarachnoid
hemorrhage (SAH, Fig. 1), 12 were nonruptured but clinically
symptomatic aneurysms (Fig. 2), one involved coil compac-
tion with aneurysm recanalization, and four were found by
other aneurismal SAH; additionally, 21 were found inciden-
tally (Fig. 3). The sizes of the aneurysms varied from 2.5 to
26 mm in their maximal dimension (mean: 9.4 mm), and the
majority of aneurysms were less than 13 mm (n ¼ 49, 77%).
The locations of aneurysms were internal carotid artery (ICA,
n ¼ 50, Figs. 1 and 2), middle cerebral artery (n ¼ 1), basilar
artery (n ¼ 4), vertebral artery (n ¼ 7, Fig. 3) or posterior
cerebral artery (n ¼ 1).
As for pharmacological therapy, in patients with nonacute
SAH, clopidogrel 150 mg and Aspirin 200 mg per day were
given for 3 days before embolization; in those patients with
acute ruptured aneurysms, a loading dose of clopidogrel
300 mg and Aspirin 300 mg was administered immediately
after the procedure. With patients under general anesthesia, the
femoral arteries were catheterized by means of a percutaneous
technique. A bolus of intravenous heparin was routinely
administered after the first or second coil was detached into
the aneurismal sac, and we maintained an activated clotting
time from 1.5 to 2 times baseline throughout the whole
procedure. The 6- or 7-French femoral sheath and guiding
catheter were introduced, followed by navigation of a 260 or
300 cm supporting microguide wire into the intracranial
branches of ICA or basilar artery. Then, a proper size andlength self-expandable Neuroform stent (Boston Scientific/
Target, Fremont, CA, USA) was negotiated into the parent
artery to bridge the aneurysm neck. The stent length was
chosen to provide at least a 5-mm landing zone beyond the
aneurysm neck on the proximal and distal parent artery. The
stent was sized to 0.3e0.5 mm greater than the caliber of the
parent vessel at the targeted landing zone.
Regarding the technique of aneurysm catheterization, 38
aneurysms were catheterized via stent mesh and coiling after
the stent was deployed. In the case of the other 25 aneurysms,
the microcatheter was navigated into the aneurysm sac before
the stent was deployed (stent-jail catheter, SJT) technique. The
selection of aneurysm catheterization largely depended on the
location of the aneurysm and on the anatomy of the parent
artery. If the aneurysm was evaluated as difficult to catheterize
via stent mesh, we preferred to select the SJC technique. After
the tip of the microcatheter was stabilized in the aneurismal
sac, the proper size and length of detachable coils were placed
into the aneurismal sac, one by one, until the aneurismal sac
Fig. 1. Images of a 45-year-old man presented with Gr2 subarachnoid hemorrhage. (A) A right carotid angiogram showed a wide-neck aneurysm in supraclinoid
internal carotid artery (ICA); (B,C) Patient underwent self-expandable stent-assisted coil embolization (SCAE) with angiographic total occlusion of aneurysm sac.
Note the proximal and distal stent marker (arrows). Follow-up angiogram at 12 months after SACE showed no evidence of recurrent aneurysm.
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by the total angiographic obliteration of the aneurismal sac, or
by the recoil of the microcatheter into the parent artery due to
difficulty of re-entry into the aneurismal sac. Of the 63
aneurysms, six were not initially intended to be treated by
SACE. In these particular cases, stenting was selected as
a salvageable procedure because of coil herniation or partial
migration into the lumen of the parent artery. Under these
circumstances, a stent was deployed into the parent artery
either to push back the coil into the aneurysm sac or to provide
fixation to the partially-migrated coils in between the arterial
wall and the stent.
Conventional postembolization angiograms were routinely
obtained to assess the effect of aneurysm occlusion, the blood
flow of the parent artery and its intracranial branches. After the
procedure, patients were given intravenous heparinization to
keep the active coagulation time (ACT) approximately twice
the baseline for 24 hours. We gave clopidogrel 150 mg daily
for 2 days, followed by clopidogrel, 75 mg daily for 6 months.
A period exceeding 6 months of angiographic and clinical
follow-up was obtained in 40 and 53 patients, respectively.
3. Results
A summary of the data on immediate follow-up angiogra-
phies and of procedure-related complications, as well as
neurologic outcomes, is presented in Table 3. Successful stent
deployment to an ideal locationdcovering the aneurysm
neckdwas observed in 60 of the 63 stents, resulting in
a deployment success rate of 95%. In one case, the stent did
not reach the proper location due to severe tortuosity of the
patient’s cavernous internal carotid artery. This patient was
alternatively treated by use of the balloon-assisted technique.
In two cases, forward jumping of the stent during deployment
lead to partial covering of the aneurismal neck, and a second
stent was deployed to fully cover the aneurysm neck. After
coiling, total occlusion of the aneurysm sac was achieved in 21
cases (33%, Fig. 1), subtotal occlusion with small neck
remnant or sac filling was accomplished in 35 cases (56%,Figs. 2 and 3), and partial treatment with loose packing was
undertaken in six cases (10%). Coiling failure only occurred in
one case (2%), but six procedure-related complications were
observed (10.2%, Table 3). Asymptomatic thromboembolic
complications including a dislodged stent with coil herniation
or partial migration occurred in four patients. Permanent
procedural morbidity was observed in two patients (3.4%).
One instance resulted from the coil perforating the aneurysm,
and presented with a modified Rankin scale (mRS) 4. The
second one had clot formation in the distal M2 of right middle
cerebral artery (MCA). Partial recanalization of the MCA was
achieved by thrombolytic therapy; ultimately, he suffered from
right limb hemiparesis (mRS 2).
Conventional angiography and clinical follow-up extending
longer than 6 months was available to 40 and 53 patients,
respectively (Table 3). The overall clinical follow-up time
ranged from 6 to 49 months (mean: 28 months). During the
follow-up period, there were no events of hemorrhage or new
events of visual impairment. With regards to the morphologic
change of embolized aneurysms, 31 (78%, Figs. 1 and 3) were
stable. Further thrombosis of the aneurysm sac occurred in
four cases (10%), while coil compaction with recurrent
aneurysm was found in five cases (13%). Furthermore, in two
cases the aneurysms were larger than 12 mm and retreatment
was initiated (Fig. 2). No evidence of stent displacement or of
significant stenosis was found in stenting parent artery.
Neurologic outcomes more than 3 months after discharge
showed 27 (51%) were mRS 0, 14 (26%) were mRS 1, 9
(17%) were mRS 2, 2 (4%) were mRS 3, and 1 (2%) was mRS
4.
4. Discussion
In the past, the balloon-mounted stent developed for coro-
nary vessels has been used to assist coil embolization.
However, the lack of flexibility necessary to navigate the
tortuosities of the carotid siphon may increase the failure rate
of the procedure.2 The advent of the self-expandable intra-
cranial stent, such as the Neuroform stent, has increased the
Fig. 2. Images of a 53-year-old woman who suffered from decreased visual acuity. (A) A right carotid angiogram revealed a huge wide-neck aneurysm at the
supraclinoid ICA; (B) Patient underwent SACE with subtotal occlusion of aneurysm sac and angiographic residual sac opacification; (C) Coil compaction with re-
canalization of aneurysm sac was found on 11-month angiographic follow-up; (D) Retreatment of recurrent aneurysm by detachable coils led to subtotal occlusion
of aneurysm sac.
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with wide-neck, unfavorable neck-to-dome ratios, or even
fusiform aneurysms, which were traditionally considered
unsuitable for detachable coil embolization. The Neuroform
stent is made of nickel titanium (nitinol) and has open-cell
struts that allow the stent to be more flexible, thus allowing
for more distal navigation and permitting the stent to conform
its shape to tortuous intracranial arteries.
Theoretically, the application of a stent within the parent
vessel for treatment of wide-neck aneurysms has three main
advantages. First, the stent can serve as a mechanical scaffold
to reconstruct the parent artery for the subsequent coil place-
ment into the aneurysm sac. In this way, the stent prevents coil
protrusion into the parent vessel, while also allowing fordenser aneurismal packing. Furthermore, there is less chance
of coil compaction with aneurismal recurrence. Second, while
the stent and its meshes only cover 6.5e9.5% of the internal
arterial surface, the intra-aneurysmal flow and velocity may be
altered and reduced from 22 to 64% after the stenting. This
may indicate favorable progressive thrombosis after stent-
ing.9,10 Therefore, the hemodynamic alterations caused by the
Neuroform stent placement appear to have a positive impact
on the long-term durability of coil embolization. The third
advantage relates to the stent itself, which may provide
a framework for endothelial growth resulting in permanent
separation of the aneurysm from the parent vessel lumen.
However, there are some drawbacks of SACE. First of all,
the stent is expensive, such that a currently available single
Fig. 3. Images of a 51-year-old woman patient presented with an asymptomatic aneurysm in the right distal vertebral artery. (A) A right vertebral angiogram
demonstrated a small wide-neck aneurysm in the distal vertebral artery; (B) She underwent SACE (arrows) leading to subtotal occlusion of aneurysm with small
residual neck. The embolized aneurysm remained stable on 24-month angiographic follow-up.
Table 3
Outcomes of 59 patients with 63 aneurysms treated by SACE.
Characteristics Number (percentage)
Immediately angiographic outcomes (n ¼ 63)
Total occlusion 21 (33)
Subtotal with neck remnant 35 (56)
Partial with loose packing 6 (10)
Failure to coiling 1 (2)
Follow-up angiographic outcomes (n ¼ 40)
Further thrombosis 4 (10)
Stable 31 (78)
Recanalization 5 (13)
Arterial stenosis. 0 (0)
Procedural-related complication (n ¼ 6)
Dislodge stent 2
Thromboembolic event 3
Aneurysm rupture 1
Neurologic outcomes (n ¼ 53)
mRS 0 27 (51)
mRS 1 14 (26)
mRS 2 9 (17)
mRS 3 2 (4)
mRS 4 1 (2)
mRS: modified Rankin scale (>3 months after discharge).
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form stent is almost invisible on the stent itself except its
proximal and distal markers. This may make it difficult to
ascertain the position of the coil inside the aneurysm sac, or it
might even cause a prolapse to the parent artery, particularly in
fusiform aneurysms. Another drawback lies in its inability to
retract once it is released into the parent artery. This can be
particularly important if the stent is deployed to an improper
location, as occurred in 2 cases in our series. Furthermore, the
stent itself is a metallic foreign body for the parent artery, so it
may induce arterial stenosis after stenting. Finally, a premed-
ication and postprocedural antiplatelet regime for several
months is necessary in order to prevent a thromboembolic
event. In addition to these limitations, navigation of the stent
to the tortuous parent artery maybe difficult. In the present
series, we successfully navigated 60 of 63 (95%) stents into
the targeted location of the parent arteries. One stent was stuck
by the ostium of the ophthalmic artery, and the patient was
eventually treated using the balloon-assisted technique.
Forward jumping of stent was found in 2 patients, and
a second stent had to be deployed to fully cover the aneurysm
neck. The success rate of stent deployment in our series was
comparable with previously published series, which ranged
from 92% to 97%.11e15
For SACE, clearly there are four strategies regarding the
timing of stent navigation and deployment in relation to
microcatheter placement and coiling. First, the traditional
method is that the stent can be first delivered across the
aneurysm neck, and then the microcatheter is placed within
the aneurysm sac through the stent mesh. While the majority
of reports showed a preference for this technique, in some-
anatomically difficult aneurysms, transmesh aneurismal cath-
eterization may be difficult to apply given the limitations of
the microcatheter’ entry angle by the stent mesh. Furthermore,
stent movements and dislodgement into the aneurysm sac maybe encountered during forceful and/ or multiple attempts to
pass the microcatheter through the stent struts. Under these
circumstances, the procedure can be interrupted and coil
embolization can be delayed for 1 to 2 months. This staged
treatment allows for stent stabilization and endothelialization,
thus enabling safer catheterization of the aneurysm.16 Second,
the microcatheter can be first placed within the aneurysm sac
to allow coil delivery, and then the stent can be positioned and
immediately delivered across the aneurysm neck, where the
microcatheter is caged between the vessel wall and the stent;
this technique is called the SJC technique. This SJC technique
permits for the stabilization of the microcatheter during coil
delivery. However, this technique may not always be possible
327C.-B. Luo et al. / Journal of the Chinese Medical Association 75 (2012) 322e328given that the stent deployment may interfere with the
microcatheter position and, in some cases, may pull out the
microcatheter from the aneurismal sac. Third, the aneurysm
can be coiled using the balloon remodeling technique, and
then the stent delivered across the aneurysm neck at the end of
the procedure, with the idea of decreasing the recanalization
rate. The fourth strategy works under the assumption that
stenting can be a salvageable procedure in those aneurismal
treatments with coil herniation or partial migration into the
parent artery after detachment. Stent deployment has the
capacity to push the coil into the aneurysm or to fix the partial
migration coil mass in between the stent and wall of the
aneurysm.2,17 In our series, this procedure was performed in 6
aneurysms.
In terms of timing of the selection of stenting technique
used in the presented series, it is largely dependent upon the
anatomy of the aneurysm and of the parent artery. If the
aneurysm was larger than 8 mm, and presumed to be easy to
catheterize such as those aneurysms in the posterior commu-
nicating artery, we preferred to deploy the stent first, followed
by catheterization via stent mesh. Alternatively, if the aneu-
rysms were smaller, and it was geographically difficult to
navigate the microcatheter, we favored the SJC technique.
This technique does improve the safety of stent-assisted coil-
ing, especially for small wide-neck aneurysms. When these
aneurysms are treated through the original paradigm of first
placing a stent, and then catheterizing the aneurysm sac
through the stent, there is often a higher likelihood of
rupturing the small wide-neck aneurysm because of difficulties
associated with passing the catheter through the stent strut.
The SJC technique obviates this risk by first securing the
microcatheter in place. This technique was particularly suit-
able for the treatment of small, acutely ruptured aneurysms
where only one coil was necessary for adequate occlusion.
Regarding immediate outcomes after postembolization,
total and subtotal angiographic aneurysm occlusion were found
in 56 aneurysms (89%), which was superior to or comparable
with previously published results. Sedat et al13 reported a 71%
total aneurysm sac occlusion rate in 42 aneurysms treated by
SACE. Biondi et al15 reported an 80% rate of total or subtotal
occlusion in 42 patients with 45 aneurysms. In the present
series, there were 6 aneurysms with partial treatment by loose
packing because of either geographically-difficult aneurysms or
due to failure of the microcatheter to re-enter the aneurysm sac
via stent mesh in case of recoil of microcatheter. In one aneu-
rysm after stenting, negotiation of the microcatheter into the
aneurysm was not successful after multiple attempts; fortu-
nately, the aneurysm had total thrombosis at the 13-month
angiographic follow-up. In 40 aneurysms with an angio-
graphic follow-up of longer than 6-months, further aneurysm
thrombosis occurred in 4 cases (10%), coil compaction with
aneurysm recurrence was found in 5 cases (13%) where aneu-
rysms were larger than 12 mm, and retreatment was initiated in
2 cases (5%). The majority of aneurysms (n¼ 31, 78%) treated
by SACE were stable at mid-term follow-up, and no significant
parent arterial stenosis induced by the stent itself was demon-
strated. These results were different from Lubicz’s series.12 Intheir 32 cases, where 34 aneurysms were treated by SACE,
immediate postembolization images showed only 33% total or
subtotal aneurysm occlusion. However, on an average 20-
month follow-up, further thrombosis was observed in 18
cases (53%) leading to an aneurysm occlusion rate of up to
86%. Additionally, asymptomatic or nonsignificant in-stent
stenosis occurred in 7 patients (22%). The higher percentage
of further thrombosis and arterial stenosis can be attributed to
the low total and subtotal occlusion rates on immediate post-
embolization, longer angiographic follow-up time (20 vs. 11
months) and use of a lower dosage of post-treatment antiplatelet
regime (160 mg Aspirin vs. 75 mg clopidogrel) in Lubicz’s
series. In terms of neurological outcomes after more than 3
months (Table 3, n¼ 53), they are dependent upon the patient’s
initial clinical presentation, such as ruptured or nonrupture
aneurysms, delayed cerebrovascular ischemia, and/or
procedure-related complications. In our series, all patients with
nonruptured aneurysms had mRS 0-1, except one patient who
had a procedure-related aneurysm rupture leading to
moderately severe disability (mRS 4). In those patients with
acute aneurismal SAH, the clinical outcomes were varied and
were related to the initial brain injury and/or presence of
delayed cerebrovascular ischemia, as well as procedure-related
complication.
Procedure-related complication occurred in seven cases
(12%). Of these, asymptomatic stent dislodgement (n ¼ 2) and
thromboembolic events (n ¼ 3) was found in 5 cases, while
one case presented with limb paresis attributable to partial
occlusion of the middle cerebral artery; acute coil perforation
with aneurysm rupture was demonstrated in 1 case, leading to
permanent neurologic defect. Therefore, procedure-related
permanent neurologic deficit was found in two patients
(3.4%) in the presented series, which was comparable or better
than those of previously published results (which range from
2.4% to 7.4%).6,10e15
In conclusion, despite a low rate of procedural complica-
tions, and some evidence of coil compaction with recurrent
aneurysm occurring in cases with larger aneurysms, SACE
was proven to be both effective and safe in managing wide-
neck intracranial aneurysms. Our results also demonstrated
the mid-term durability and stability of aneurysms treated by
SACE. Furthermore, stenting can be a salvageable procedure
in cases with coil herniation or partial migration into the
parent artery.
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